JP2025506504A5 - - Google Patents

Info

Publication number
JP2025506504A5
JP2025506504A5 JP2024547671A JP2024547671A JP2025506504A5 JP 2025506504 A5 JP2025506504 A5 JP 2025506504A5 JP 2024547671 A JP2024547671 A JP 2024547671A JP 2024547671 A JP2024547671 A JP 2024547671A JP 2025506504 A5 JP2025506504 A5 JP 2025506504A5
Authority
JP
Japan
Application number
JP2024547671A
Other languages
Japanese (ja)
Other versions
JP2025506504A (ja
JPWO2023156450A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/053744 external-priority patent/WO2023156450A1/en
Publication of JP2025506504A publication Critical patent/JP2025506504A/ja
Publication of JP2025506504A5 publication Critical patent/JP2025506504A5/ja
Publication of JPWO2023156450A5 publication Critical patent/JPWO2023156450A5/ja
Pending legal-status Critical Current

Links

JP2024547671A 2022-02-15 2023-02-15 治療用フェネチルアミン組成物及び使用方法 Pending JP2025506504A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263268019P 2022-02-15 2022-02-15
US202263268022P 2022-02-15 2022-02-15
US63/268,022 2022-02-15
US63/268,019 2022-02-15
US202263386375P 2022-12-07 2022-12-07
US63/386,375 2022-12-07
PCT/EP2023/053744 WO2023156450A1 (en) 2022-02-15 2023-02-15 Therapeutic phenethylamine compositions and methods of use

Publications (3)

Publication Number Publication Date
JP2025506504A JP2025506504A (ja) 2025-03-11
JP2025506504A5 true JP2025506504A5 (https=) 2026-02-20
JPWO2023156450A5 JPWO2023156450A5 (https=) 2026-02-20

Family

ID=85278498

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547671A Pending JP2025506504A (ja) 2022-02-15 2023-02-15 治療用フェネチルアミン組成物及び使用方法

Country Status (7)

Country Link
US (1) US20250236589A1 (https=)
EP (1) EP4479373A1 (https=)
JP (1) JP2025506504A (https=)
KR (1) KR20240153566A (https=)
AU (1) AU2023222397A1 (https=)
CA (1) CA3244275A1 (https=)
WO (1) WO2023156450A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12122741B2 (en) 2020-08-18 2024-10-22 Cybin Irl Limited Therapeutic phenethylamine compositions and methods of use
WO2025228547A1 (en) * 2024-05-01 2025-11-06 Cybin Irl Limited Processes for preparing phenethylamine compounds
WO2026030444A1 (en) * 2024-07-30 2026-02-05 Otsuka America Pharmaceutical, Inc Compounds useful for the treatment of disorders and methods related thereto

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US5612059A (en) 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
ATE141502T1 (de) 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5798119A (en) 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
ID28302A (id) 1999-01-14 2001-05-10 Teijin Ltd Alat untuk mengumpankan suatu bubuk dalam jumlah tertentu
GB0114272D0 (en) 2001-06-12 2001-08-01 Optinose As Nasal delivery device
GB0121568D0 (en) 2001-09-06 2001-10-24 Optinose As Nasal delivery device
NZ514442A (en) 1999-03-03 2003-08-29 Optinose As Nasal delivery device
GB0019715D0 (en) 2000-08-10 2000-09-27 Pa Consulting Services Device for delivering physiologically active agent in powdered form
ZA200306564B (en) 2001-02-26 2004-10-15 Optinose As Nasal devices.
JP4795637B2 (ja) 2001-09-28 2011-10-19 カーブ テクノロジー,インコーポレイティド 鼻ネブライザー
GB0207422D0 (en) 2002-03-28 2002-05-08 Optinose As Nasal devices
GB0207817D0 (en) 2002-04-04 2002-05-15 Optinose As Nasal devices
GB0209494D0 (en) 2002-04-25 2002-06-05 Optinose As Nasal devices
US7267121B2 (en) 2004-04-20 2007-09-11 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
RU199823U1 (ru) 2020-06-10 2020-09-21 Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий Устройство для лечения бронхолегочных заболеваний

Similar Documents

Publication Publication Date Title
JP2025506504A5 (https=)
CA3250564A1 (https=)
BR202022009269U2 (https=)
CN307045612S (https=)
BY13153U (https=)
CN307044566S (https=)
CN307044438S (https=)
CN307044326S (https=)
CN306712331S8 (https=)
CN306636407S9 (https=)
BY24009C1 (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13145U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
BY13144U (https=)
BY13167U (https=)
BY13166U (https=)
BY13165U (https=)
BY13164U (https=)
BY13163U (https=)